INTERNATIONAL PATENT: HYLORIS DEVELOPMENTS SA FILES APPLICATION FOR "INTRAVENOUS ADMINISTRATION OF TICAGRELOR COMPOSITIONS IN A PATIENT WHO WAS PREVIOUSLY ADMINISTERED AN OPIOID IN ORDER TO TREAT COAGULATION AND AVOID REDUCED TICAGRELOR UPTAKE"

GENEVA, June 2 -- HYLORIS DEVELOPMENTS SA (Boulevard Patience et Beaujonc Ndeg3/14000 Liege) filed a patent application (PCT/EP2024/082952) for "INTRAVENOUS ADMINISTRATION OF TICAGRELOR COMPOSITIONS IN A PATIENT WHO WAS PREVIOUSLY ADMINISTERED AN OPIOID IN ORDER TO TREAT COAGULATION AND AVOID REDUCED TICAGRELOR UPTAKE" on Nov 20, 2024. With publication no. WO/2025/108980, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PATIL, Atul (p/a Hyloris Developments SA, Boulevard Patience et Beaujonc Ndeg3/14000 Liege), EECKHAOUDT,...